BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38668781)

  • 1. Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.
    Wang Y; Huang Z; Li B; Xue J; Guo C; Bing Z; Zheng Z; Song Y; Xu Y; Huang G; Li H; Yu X; Xia Y; Li R; Si X; Zhang L; Li J; Song L; Xiong Y; Gu D; Song M; Zhou Z; Chen R; Feng Z; Bie Z; Li X; Yang H; Li S; Liang N
    Cancer Immunol Immunother; 2024 Apr; 73(6):111. PubMed ID: 38668781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and immune characteristics of multiple primary lung cancers and lung metastases.
    Yang R; Li P; Wang D; Wang L; Yin J; Yu B; Li M; Wang S; Wang Y
    Thorac Cancer; 2021 Oct; 12(19):2544-2550. PubMed ID: 34510768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
    Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
    J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
    Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
    Miyauchi E; Matsuda T; Kiyotani K; Low SK; Hsu YW; Tsukita Y; Ichinose M; Sakurada A; Okada Y; Saito R; Nakamura Y
    Cancer Sci; 2019 Mar; 110(3):867-874. PubMed ID: 30582659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic characteristics of early-stage multiple primary and independent primary lung adenocarcinoma patients.
    Li P; Yang R; Wang D; Wang L; Wang S; Liu C; Li J; Li L; Liu C; Tong Y; Wang Y
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e420-e426. PubMed ID: 35098658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic characteristics and immune landscape of super multiple primary lung cancer.
    Yang Z; Zhou B; Guo W; Peng Y; Tian H; Xu J; Wang S; Chen X; Hu B; Liu C; Wang Z; Li C; Gao S; He J
    EBioMedicine; 2024 Mar; 101():105019. PubMed ID: 38364701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy.
    Zhang C; Yin K; Liu SY; Yan LX; Su J; Wu YL; Zhang XC; Zhong WZ; Yang XN
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33820821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evolutionary convergence in multiple primary lung cancer suggests insufficient specificity of personalized therapy.
    Cheng H; Guo Z; Zhang X; Wang XJ; Li Z; Huo WW; Zhong HC; Li XJ; Wu XW; Li WH; Chen ZW; Wu TC; Gan XF; Zhong BL; Lyubetsky VA; Rusin LY; Yang J; Zhao Q; Cao QD; Yang JR
    J Genet Genomics; 2023 May; 50(5):330-340. PubMed ID: 36414223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis.
    Tian H; Wang Y; Yang Z; Chen P; Xu J; Tian Y; Fan T; Xiao C; Bai G; Li L; Zheng B; Li C; He J
    Cancer Gene Ther; 2023 Mar; 30(3):507-520. PubMed ID: 36653483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients.
    Liang Z; Zeng G; Wan W; Deng B; Chen C; Li F; Lin G; Lin Y; Lin H; Mo G; Miao H
    Discov Med; 2023 Apr; 35(175):131-143. PubMed ID: 37188510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study.
    Song Y; Jia Z; Wu P; Wang W; Ou Q; Bao H; Yu M; Wu X; Liu P; Liang N; Zhang S; Li S
    BMC Pulm Med; 2020 Apr; 20(1):80. PubMed ID: 32245453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
    Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report.
    Yang Y; Xie X; Jiang G; Liu H
    J Cardiothorac Surg; 2020 Jul; 15(1):196. PubMed ID: 32727606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patients.
    Massa C; Robins H; Desmarais C; Riemann D; Fahldieck C; Fornara P; Seliger B
    Oncotarget; 2017 Mar; 8(13):21212-21228. PubMed ID: 28177902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
    Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
    Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer.
    Liu YY; Yang QF; Yang JS; Cao RB; Liang JY; Liu YT; Zeng YL; Chen S; Xia XF; Zhang K; Liu L
    Int J Cancer; 2019 Sep; 145(5):1423-1431. PubMed ID: 30664810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and outcomes of patients with stage I multiple primary lung cancers.
    Shintani Y; Okami J; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Asamura H; Chida M; Date H; Endo S; Nagayasu T; Nakanishi R; Miyaoka E; Okumura M; Yoshino I;
    Cancer Sci; 2021 May; 112(5):1924-1935. PubMed ID: 33236385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection.
    Wang Y; Duan F; Zhu Z; Yu M; Jia X; Dai H; Wang P; Qiu X; Lu Y; Huang J
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.